Get the Stockscreener App
43.82
0.59%
-0.26
After Hours:
43.82
Monster Beverage Corp stock is traded at $43.82, with a volume of 12.03M.
It is down -0.59% in the last 24 hours and down -53.47% over the past month.
Monster Beverage is a leader in the energy drink category within the nonalcoholic ready-to-drink beverage market, generating two-thirds of revenue in the US and Canada. The well-known Monster trademark includes brands such as Monster Energy, Monster Ultra, Java Monster, and Juice Monster. The firm also owns other energy drink brands, such as Reign, NOS, Burn, Bang, and Mother, and brews and distributes beers and flavored malt beverages following the acquisition of a craft brewer in 2022. Monster controls branding and innovation but outsources beverage manufacturing and packaging to co-packers and finished goods distribution to bottlers in the global Coca-Cola system (pursuant to a 20-year agreement inked in 2015). Coke is the largest shareholder of Monster, owning a 20% stake.
See More
Previous Close:
$44.08
Open:
$43.78
24h Volume:
12.03M
Relative Volume:
1.76
Market Cap:
$85.85B
Revenue:
$8.79B
Net Income/Loss:
$2.03B
P/E Ratio:
21.27
EPS:
2.0606
Net Cash Flow:
$2.05B
1W Performance:
-6.49%
1M Performance:
-53.47%
6M Performance:
-44.26%
1Y Performance:
-30.94%
1-Day Range:
$43.65
$44.17
1-Week Range:
$43.65
$46.66
52-Week Range:
$43.65
$100.34
Monster Beverage Corp Stock (MNST) Company Profile
Name
Monster Beverage Corp
Sector
Industry
Phone
909-739-6200
Address
1 MONSTER WAY, CORONA, CA
Compare MNST vs KO, PEP, KOF, COKE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MNST
Monster Beverage Corp
|
43.82 | 93.04B | 8.79B | 2.03B | 2.05B | 2.0606 |
KO
Coca Cola Co
|
88.07 | 389.38B | 49.82B | 13.77B | 12.56B | 3.1761 |
PEP
Pepsico Inc
|
137.63 | 193.92B | 96.91B | 10.52B | 9.28B | 7.6247 |
KOF
Coca Cola Femsa Sab De Cv Adr
|
112.00 | 23.79B | 15.88B | 1.31B | 727.67M | 5.9296 |
COKE
Coca Cola Consolidated Inc
|
189.33 | 12.49B | 7.49B | 578.53M | 665.12M | 6.8502 |
Monster Beverage Corp Stock (MNST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-23-26 | Reiterated | Stifel | Buy |
| Apr-20-26 | Reiterated | TD Cowen | Hold |
| Apr-10-26 | Reiterated | BofA Securities | Buy |
| Apr-08-26 | Reiterated | Wells Fargo | Overweight |
| Apr-07-26 | Reiterated | UBS | Neutral |
| Mar-16-26 | Reiterated | Wells Fargo | Overweight |
| Mar-03-26 | Reiterated | Argus | Buy |
| Feb-27-26 | Reiterated | Citigroup | Buy |
| Feb-27-26 | Reiterated | Deutsche Bank | Buy |
| Feb-27-26 | Reiterated | Evercore ISI | Outperform |
| Feb-27-26 | Reiterated | JP Morgan | Neutral |
| Feb-27-26 | Reiterated | Jefferies | Buy |
| Feb-27-26 | Reiterated | Piper Sandler | Overweight |
| Feb-27-26 | Reiterated | Stifel | Buy |
| Feb-27-26 | Reiterated | TD Cowen | Hold |
| Feb-27-26 | Reiterated | UBS | Neutral |
| Feb-27-26 | Reiterated | Wells Fargo | Overweight |
| Feb-24-26 | Reiterated | RBC Capital Mkts | Outperform |
| Feb-23-26 | Reiterated | Evercore ISI | Outperform |
| Feb-20-26 | Reiterated | Deutsche Bank | Buy |
| Jan-27-26 | Reiterated | Argus | Buy |
| Jan-26-26 | Reiterated | Morgan Stanley | Overweight |
| Jan-16-26 | Upgrade | BNP Paribas Exane | Underperform → Neutral |
| Jan-14-26 | Reiterated | Citigroup | Buy |
| Jan-14-26 | Reiterated | UBS | Neutral |
| Jan-08-26 | Reiterated | TD Cowen | Hold |
| Jan-05-26 | Reiterated | Wells Fargo | Overweight |
| Dec-19-25 | Reiterated | BofA Securities | Buy |
| Dec-03-25 | Reiterated | BMO Capital Markets | Market Perform |
| Dec-03-25 | Reiterated | Goldman | Buy |
| Dec-03-25 | Reiterated | Piper Sandler | Overweight |
| Dec-03-25 | Reiterated | Wells Fargo | Overweight |
| Dec-01-25 | Reiterated | Piper Sandler | Overweight |
| Dec-01-25 | Reiterated | RBC Capital Mkts | Outperform |
| Nov-07-25 | Reiterated | BofA Securities | Buy |
| Nov-07-25 | Reiterated | Deutsche Bank | Buy |
| Nov-07-25 | Reiterated | Evercore ISI | Outperform |
| Nov-07-25 | Reiterated | Goldman | Buy |
| Nov-07-25 | Reiterated | JP Morgan | Neutral |
| Nov-07-25 | Reiterated | Morgan Stanley | Overweight |
| Nov-07-25 | Reiterated | Piper Sandler | Overweight |
| Nov-07-25 | Reiterated | UBS | Neutral |
| Nov-07-25 | Reiterated | Wells Fargo | Overweight |
| Oct-30-25 | Reiterated | Deutsche Bank | Buy |
| Oct-24-25 | Reiterated | JP Morgan | Neutral |
| Oct-24-25 | Reiterated | Stifel | Buy |
| Oct-10-25 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-08-25 | Reiterated | UBS | Neutral |
| Sep-16-25 | Reiterated | Citigroup | Buy |
| Aug-13-25 | Reiterated | Roth Capital | Neutral |
| Aug-08-25 | Reiterated | JP Morgan | Neutral |
| Aug-08-25 | Reiterated | Morgan Stanley | Overweight |
| Aug-08-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-08-25 | Reiterated | RBC Capital Mkts | Outperform |
| Aug-08-25 | Reiterated | UBS | Neutral |
| Aug-08-25 | Reiterated | Wells Fargo | Overweight |
| Jul-17-25 | Reiterated | UBS | Neutral |
| Jul-09-25 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| Jun-13-25 | Reiterated | Goldman | Buy |
| Jun-13-25 | Reiterated | Wells Fargo | Overweight |
| Jun-12-25 | Reiterated | Morgan Stanley | Overweight |
| Jun-12-25 | Resumed | Stifel | Buy |
| May-14-25 | Reiterated | Roth Capital | Neutral |
| May-09-25 | Reiterated | JP Morgan | Neutral |
| May-09-25 | Reiterated | Morgan Stanley | Overweight |
| May-09-25 | Reiterated | Piper Sandler | Neutral |
| May-09-25 | Reiterated | TD Cowen | Hold |
| May-09-25 | Reiterated | UBS | Neutral |
| May-05-25 | Reiterated | Wells Fargo | Overweight |
| May-02-25 | Reiterated | JP Morgan | Neutral |
| Apr-25-25 | Reiterated | BofA Securities | Buy |
| Apr-23-25 | Reiterated | Truist | Sell |
| Apr-17-25 | Reiterated | UBS | Neutral |
| Apr-16-25 | Reiterated | Jefferies | Buy |
| Apr-14-25 | Reiterated | Citigroup | Buy |
| Apr-02-25 | Reiterated | Wells Fargo | Overweight |
| Mar-03-25 | Reiterated | UBS | Neutral |
| Feb-28-25 | Reiterated | Citigroup | Buy |
| Feb-28-25 | Reiterated | Deutsche Bank | Buy |
| Feb-28-25 | Reiterated | JP Morgan | Neutral |
| Feb-28-25 | Reiterated | Morgan Stanley | Overweight |
| Dec-19-24 | Reiterated | Exane BNP Paribas | Underperform |
| Dec-06-24 | Initiated | Needham | Hold |
| Nov-12-24 | Reiterated | Argus | Buy |
| Nov-11-24 | Reiterated | TD Cowen | Hold |
| Nov-08-24 | Reiterated | Deutsche Bank | Buy |
| Nov-08-24 | Reiterated | JP Morgan | Neutral |
| Nov-08-24 | Reiterated | Stifel | Buy |
| Nov-08-24 | Reiterated | UBS | Neutral |
| Nov-05-24 | Reiterated | Wells Fargo | Overweight |
| Nov-04-24 | Reiterated | JP Morgan | Neutral |
| Oct-15-24 | Reiterated | BofA Securities | Buy |
| Oct-07-24 | Reiterated | UBS | Neutral |
| Aug-12-24 | Reiterated | ROTH MKM | Neutral |
| Aug-09-24 | Reiterated | Truist | Sell |
| Aug-08-24 | Reiterated | Citigroup | Buy |
| Aug-08-24 | Reiterated | Deutsche Bank | Buy |
| Aug-08-24 | Reiterated | JP Morgan | Neutral |
| Aug-08-24 | Reiterated | Jefferies | Buy |
| Aug-08-24 | Reiterated | Piper Sandler | Neutral |
| Aug-08-24 | Reiterated | RBC Capital Mkts | Outperform |
| Aug-08-24 | Reiterated | UBS | Neutral |
| Aug-08-24 | Reiterated | Wells Fargo | Overweight |
| Jul-23-24 | Reiterated | JP Morgan | Neutral |
| Jul-15-24 | Reiterated | TD Cowen | Hold |
| Jul-10-24 | Reiterated | BofA Securities | Buy |
| Jul-10-24 | Reiterated | Citigroup | Buy |
| Jun-25-24 | Reiterated | Wells Fargo | Overweight |
| Jun-24-24 | Initiated | Exane BNP Paribas | Underperform |
| Jun-17-24 | Reiterated | Stifel | Buy |
| May-03-24 | Reiterated | Morgan Stanley | Overweight |
| May-03-24 | Reiterated | Piper Sandler | Neutral |
| May-03-24 | Reiterated | UBS | Neutral |
| Jan-17-24 | Reiterated | BMO Capital Markets | Market Perform |
| Jan-17-24 | Reiterated | Citigroup | Buy |
| Jan-17-24 | Reiterated | Goldman | Buy |
| Jan-17-24 | Reiterated | JP Morgan | Overweight |
| Nov-20-23 | Reiterated | Piper Sandler | Neutral |
| Nov-20-23 | Reiterated | ROTH MKM | Neutral |
| Nov-13-23 | Initiated | Jefferies | Buy |
| Nov-03-23 | Reiterated | Wells Fargo | Overweight |
| Oct-31-23 | Reiterated | JP Morgan | Overweight |
| Oct-24-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-23-23 | Reiterated | Deutsche Bank | Buy |
| Oct-05-23 | Upgrade | CFRA | Hold → Buy |
| Aug-14-23 | Initiated | HSBC Securities | Buy |
| Aug-10-23 | Reiterated | ROTH MKM | Neutral |
| Aug-07-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-04-23 | Reiterated | UBS | Neutral |
| Jul-31-23 | Reiterated | Stifel | Buy |
| Jul-25-23 | Reiterated | Evercore ISI | Outperform |
| Jun-08-23 | Initiated | Piper Sandler | Neutral |
| May-08-23 | Reiterated | BMO Capital Markets | Market Perform |
| May-08-23 | Reiterated | ROTH MKM | Neutral |
| May-05-23 | Reiterated | BofA Securities | Buy |
| May-05-23 | Reiterated | Citigroup | Buy |
| May-05-23 | Reiterated | Deutsche Bank | Buy |
| May-05-23 | Reiterated | Goldman | Buy |
| May-05-23 | Reiterated | JP Morgan | Overweight |
| May-05-23 | Reiterated | Morgan Stanley | Overweight |
| May-05-23 | Reiterated | RBC Capital Mkts | Outperform |
| May-05-23 | Reiterated | Truist | Buy |
| May-05-23 | Reiterated | UBS | Neutral |
| May-05-23 | Reiterated | Wells Fargo | Overweight |
| Apr-06-23 | Reiterated | UBS | Neutral |
| Apr-06-23 | Reiterated | Wedbush | Neutral |
| Mar-06-23 | Upgrade | Redburn | Neutral → Buy |
| Mar-01-23 | Reiterated | BMO Capital Markets | Market Perform |
| Mar-01-23 | Downgrade | CFRA | Buy → Hold |
| Mar-01-23 | Reiterated | Citigroup | Buy |
| Mar-01-23 | Reiterated | JP Morgan | Overweight |
| Mar-01-23 | Reiterated | Morgan Stanley | Overweight |
| Mar-01-23 | Reiterated | Truist | Buy |
| Mar-01-23 | Reiterated | Wells Fargo | Overweight |
| Feb-17-23 | Initiated | Citigroup | Buy |
| Jan-18-23 | Reiterated | BMO Capital Markets | Market Perform |
| Jan-18-23 | Reiterated | Evercore ISI | Outperform |
| Nov-04-22 | Reiterated | BofA Securities | Buy |
| Nov-04-22 | Reiterated | Morgan Stanley | Overweight |
| Nov-04-22 | Reiterated | RBC Capital Mkts | Outperform |
| Nov-04-22 | Reiterated | UBS | Neutral |
| Nov-04-22 | Reiterated | Wells Fargo | Overweight |
| Nov-01-22 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-11-22 | Initiated | Wedbush | Neutral |
| Aug-05-22 | Reiterated | RBC Capital Mkts | Outperform |
| Jul-05-22 | Initiated | ROTH Capital | Neutral |
| Jun-06-22 | Reiterated | Morgan Stanley | Overweight |
| May-18-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Feb-25-22 | Reiterated | Citigroup | Buy |
| Feb-25-22 | Reiterated | Cowen | Market Perform |
| Feb-25-22 | Reiterated | Deutsche Bank | Buy |
| Feb-25-22 | Reiterated | Guggenheim | Buy |
| Feb-25-22 | Reiterated | JP Morgan | Neutral |
| Feb-17-22 | Initiated | BMO Capital Markets | Market Perform |
| Nov-01-21 | Initiated | Redburn | Neutral |
| Oct-13-21 | Downgrade | Jefferies | Buy → Hold |
| Jul-23-21 | Upgrade | Citigroup | Neutral → Buy |
| May-07-21 | Reiterated | Truist | Buy |
| Feb-26-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Jan-20-21 | Initiated | Bernstein | Mkt Perform |
| Jan-15-21 | Reiterated | Citigroup | Neutral |
| Jan-15-21 | Reiterated | Deutsche Bank | Buy |
| Jan-15-21 | Reiterated | Truist | Buy |
| Dec-10-20 | Reiterated | Morgan Stanley | Overweight |
| Dec-08-20 | Initiated | Wells Fargo | Overweight |
| Nov-17-20 | Upgrade | UBS | Sell → Neutral |
| Nov-03-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-20-20 | Reiterated | Guggenheim | Buy |
| May-28-20 | Reiterated | Stifel | Buy |
| May-11-20 | Downgrade | Citigroup | Buy → Neutral |
| May-05-20 | Reiterated | Guggenheim | Buy |
| Apr-16-20 | Resumed | BofA/Merrill | Buy |
| Apr-01-20 | Resumed | Goldman | Buy |
| Mar-20-20 | Upgrade | Guggenheim | Neutral → Buy |
| Mar-18-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Feb-03-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-17-19 | Downgrade | Cowen | Outperform → Market Perform |
| Oct-02-19 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-08-19 | Reiterated | BMO Capital Markets | Market Perform |
| Aug-08-19 | Reiterated | Morgan Stanley | Equal-Weight |
| Aug-08-19 | Reiterated | UBS | Sell |
| Apr-01-19 | Downgrade | Macquarie | Outperform → Neutral |
| Mar-28-19 | Reiterated | Morgan Stanley | Equal-Weight |
View All
Monster Beverage Corp Stock (MNST) Latest News
Monster Beverage | 4: Statement of changes in beneficial ownership of securities-Director JACKSON JEANNE P - Moomoo
Monster Beverage Corporation (MNST) Appoints Matthew S. Burroughs as Chief Accounting Officer and Deputy CFO - GuruFocus
Monster Beverage Appoints Matthew S. Burroughs as Chief Accounting Officer and Deputy CFO - Kalkine Media
Monster Beverage Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Monster Beverage Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Monster Beverage Corp. (MNST) News, Articles, Events & Latest Updates - Stocktwits
(: -MONSTER BEVERAGE CORP) Stock Price, News & Analysis - kalkine.ca
Monster Beverage (NASDAQ:MNST) Earnings Beat Puts Growth In Focus - Kalkine Media
Monster Beverage Corporation (NASDAQ:MNST) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Monster Beverage Corp. stock underperforms Monday when compared to competitors - MarketWatch
Will Monster Beverage's Expansion and Innovation Fuel Growth? - Yahoo Finance
Monster Beverage Corporation (NASDAQ:MNST) Short Interest Update - MarketBeat
If You Invested $100 In Monster Beverage Stock 15 Years Ago, You Would Have This Much Today - Benzinga
Monster Beverage (NASDAQ:MNST) Stock Price Crosses Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Monster Beverage Is Making More Money Than Its Brewing Division Can Lose - VinePair
Monster Beverage Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Monster Run: This Consumer Stock Turned $1,000 Into $1M Over 22 Years - Stocktwits
Monster Beverage Corp. stock outperforms competitors on strong trading day - MarketWatch
Monster Beverage stock holds firm as Q2 2026 growth and new labelling rules shape outlook - Ad-hoc-news.de
Monster Beverage (NASDAQ:MNST) Shows Strong Technical Breakout Setup - ChartMill
Monster Beverage (NASDAQ:MNST) Breaks Higher As Market Focus Grows - Kalkine Media
Monster Beverage (NASDAQ:MNST) Shares Cross Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Monster Beverage stock holds near recent highs as valuation debate intensifies - Ad-hoc-news.de
AB Tax-Managed Wealth Appreciation Strategy's Monster Beverage Corp(MNST) Holding History - GuruFocus
Is Monster Beverage Corp (MNST) Overvalued After 4.1% Rally? GF - GuruFocus
Why Monster Beverage (MNST) Stock Is Up Today - Moomoo
Can Monster Energy's 22% Segment Growth Keep Driving MNST? - Yahoo Finance
Coca-Cola's Volume vs Price Mix: What's Driving Growth Now? - TradingView
HSBC Adjusts Price Target on Monster Beverage to $52 From $50, Maintains Buy Rating - marketscreener.com
The Bull Case For Monster Beverage (MNST) Could Change Following Strong Q2 Results And Zero Sugar Momentum - simplywall.st
$1000 Invested In Monster Beverage 15 Years Ago Would Be Worth This Much Today - Benzinga
Monster Beverage (NASDAQ:MNST): Strong Growth Meets a Promising Technical Setup - ChartMill
Monster Beverage stock steadies after Q2 earnings beat as margin questions linger - ad-hoc-news.de
Monster’s energy drinks surge as alcohol sales fall 15% - The Drinks Business
Monster Beverage (MNST) Stock Looks Near Fair Value While Earnings Price In More - simplywall.st
Monster Beverage Corporation (MNST) Stock Forecasts - Yahoo Finance
Monster Beverage achieves monster results - Food Business News
Rep. Josh Gottheimer Purchases Shares of Monster Beverage Corporation (NASDAQ:MNST) - MarketBeat
Will Strong Q2 2026 International-Driven Results Change Monster Beverage's (MNST) Margin and Growth Narrative? - Yahoo Finance
Monster Beverage Stock Split: Why MNST Shares Double, Not Value on August 11 - EBC Financial Group
Is iShares US Consumer Staples ETF a Better Buy Than Invesco Food & Beverage? - The Motley Fool
Fund Update: 153,098 MONSTER BEVERAGE (MNST) shares added to Vanguard Personalized Indexing Management, LLC portfolio - Quiver Quantitative
Monster Beverage Corp Stock (MNST) Moved Down by 49.76% on Aug 11: Key Drivers Unveiled - TradingKey
Why is Monster Beverage stock climbing today? By Investing.com - Investing.com UK
MNST Q2 Deep Dive: International Acceleration, Margin Compression, and Innovation Drive Focus - Yahoo Finance
Monster Beverage Rallies on Split, Earnings, Upgrades - TradingPedia
Why is Monster Beverage stock climbing today? - Investing.com
MNST Looks 16.0% Overvalued on GF Value™ as Market Reacts to Q2 EPS - GuruFocus
Monster Beverage stock hits 52-week low at $45.72 By Investing.com - Investing.com UK
Monster Beverage stock hits 52-week low at $45.72 - Investing.com
Why Monster Beverage (MNST) Is Back In The Spotlight - simplywall.st
Monster Beverage Corp Stock (MNST) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
0.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):